Revision cards Flashcards
(239 cards)
How has tissue repair and regeneration been present throughout history?
Greek mythology: Prometheus’ liver could regenerate overnight.
275AD: St. Cosme and St. Damian supposedly performed first tissue transplant.
Middle ages: Quest for regeneration through fountain of youth and philosopher’s stone.
1600/1700s: Glanwill made predications that “restoration of grey hairs to juvenility and renewing of exhausted marrow” would be possible.
1868: Ernst Haeckel first used the term ‘stem cells’ coming from ‘stammzelle’ originally used in a phylogenetic context.
1892: Boveri shows SCs are those between fertilised egg and committed germ cells.
1892: Hacker showed that cyclops embryo underwent asymmetric division.
1905: Pappenheim related hematopoiesis to stem cells.
What is a stem cell?
Cells that have the potential to generate different specialized tissue (differentiation) as well as copies of themselves (self-replication).
What are the different ways we can classify stem cells?
- Age of development (embryo or adult)
- Tissue of origin (neural/hematopoietic/umblical cord etc)
- Basis of how many cells they can produce
How can stem cells be classified according to the different cells they can produce?
- Totipotent: all cell types of the human body including thromboblast e.g. zygote
- Pluripotent: derivative from 3 germ layers e.g. embryonic stem cells
- Multipotent: different cell types from a tissue or organ e.g. neural, blood, renal etc
- Unipotent: single cell types e.g. muscle satellite cell
How does differentiation affect the rate of the cell cycle?
Stem cells in the stem cell niche have a slow cell cycle (although this is different in vitro). Once they reach a stage where they are directed to a fate and begin to differentiate (trans-amplifying cells) the speed of cell cycle begins to increase.
How can stem cells be used in a clinical context?
Allogeneic - stem cells derived from a different donor, expanded and stored in the lab before being used to treat other people. e.g. ESC, cord blood cells
Auto-transplant - stem cells to be transplanted are derived from the same patient e.g. from bone marrow, generation of iPS from skin/blood cells by adding Sox2, Oct4, Myc, Klf4
Medicinal interactions with stem cells - recruitment of endogenous stem cells from the same tissue. Use medicines to ‘awaken’ stem cells in the damaged tissues to activate them to repair it.
How can stem cells aid biomedical science?
- Excellent models to screen new drugs
- Models to study genetic conditions (specifically iPS)
- Models to combine the former two (pharmacogenomics) to look for a drug which will compensate a phenotype caused by genes
- Insight into fundamental biological problems
- Direct, potential clinical application for therapeutics
Why are the pathways involved with stem cell differentiation important?
To most, it may seem like you simply flip a switch to cause a stem cell to differentiate into a specific fate. In reality there are many pathways that affect progression.
Loebel et al (2004) said that manipulating stem cell differentiation should be based on what we know of what causes lineage decisions in early embryogenesis.
Is regenerative medicine a new concept?
No! There have been various experiments/transplantations that have been carried out over the years.
- Bone marrow transplantation (1950s)
- Corneal grafts
- Skin grafts for burns victims
- First successful kidney transplant in 1954
- First heart transplant in 1967
What are some of the key issues that need to be addressed before stem cells are used routinely therapeutically?
- Efficacy
- Safety
- Purity and controlled manufacture process
- Identification/maintenance/culture of large no. of stem cells in vitro
- Effective differentiation of stem cells in vitro
- Immunological rejection concerns
- Assessment of functionality
- Identifying and weighing up the risks
- Ethical issues
How are stem cells involved with anti-cancer therapeutics?
Most current anti-cancer treatments work to kill the cancer stem cells themselves which contribute to the rapidly expanding trans-amplifying cells that contribute to the tumour. But they identified that the cancer stem cells were giving rise to tumour progenitors as well which could avoid the anti-cancer treatment. Therefore it is crucial to develop anti-cancer drugs that will target cancer stem cells and progenitor cells.
What recent Nobel prize research has provided advances in stem cell biology?
NP 2007: Capecchi, Evans and Amithies introduced specific gene modifications in mice using embryonic stem cells.
NP 2010: Robert G. Edwards developed in vitro fertilisation.
NP 2012: Gurdon and Yamanaka discovered that mature cells can be reprogrammed to become pluripotent.
Where did the discovery of embryonic stem cells begin?
Stevens et al 1954 found that tetratomas could spontaneously develop in the gonads in stain 129 mice. These tetratomas developed multiple tissue types including hair and teeth, and many structures similar to that seen in embryonic development.
How did the characterisation of embryonic carcinoma cells lead to isolation of embryonic stem cells?
Kleinsmith and Pierce (1964) found that these embryonic carcinoma cells had multipotentcy (capacity to produce all aspects of tumour tissues).
Brinster (1974) put embryonic carcinoma cells from a dark mouse into a light mouse blastocyst to show that the cells became integrated into all tissues to form a chimera.
Evans and Martin simultaneously in 1981 identified that there must be cells in normal development that have similar properties to the embryonic carcinoma cells. They isolated embryonic stem cells from the mouse and grew them on feeder layers.
How were embryonic stem cells isolated?
Martin et al (1981) isolated the emrbyonic stem cells from the blastocyst and placed them on feeder cells. These are embryonic fibroblasts that are treated with chemicals or radiation to stop them from differentiated. They provide the signals needed for the ESCs to stay alive and undifferentiated. This allowed embryoid bodies to form.
The ESCs were tested by injecting them into another mouse blastocyst to create a chimera or implantation into an adult mouse to create a tumour.
What are the properties of embryonic stem cells?
- Derived from the inner cell mass of blastocysts
- Non-transformed, genetically fairly stable
- Indefinite proliferative potential, high amplification capacity
- Stable diploid karyotype (hES less than mES)
- Clonogenic - can grow from a single cell (harder with hES)
- Pluripotent - can generate all fetal and adult cell types in vitro and in vivo and in tetratoma/carcinoma (can’t test all of this for hES cells)
- Incorporation in chimeras (ethical issues with hES although shown in 2016)
- Germline transmission in chimeras - well established in mice (ethical issues with hES)
- Permissive to genetic manipulation
How can you genetically manipulate stem cells in an organism and then visualise gene expression?
Mouse embryonic stem cells injected into a blastocyst will incorporate into all embryonic cell types. You can genetically modify genes to make a reporter line along with a mutation, so a reporter can be used to visualise gene expression. For example, GFP, RFP, or b-galactosidase where you add a substrate to cause it to stain blue.
What on the feeder cell layer causes ESCs to be maintained as undifferentiated?
Leukaemia inhibitory factor is present on feeder layers and controls the proliferation and self-renewal of the stem cells.
LIF interacts with the LIF receptor at the plasma membrane which is associated with gp130. Once bound, LIF initiates the activation of JAK which activates STAT3 to move into the nucleus and contribute to self-renewal.
LIF also activates the Akt pathway which causes the activation of SHP-2 which activates ERK1/2. ERK1/2 inhibits STAT3 and drives proliferation and differentiation.
What happens to the ESCs in the presence or absence of LIF?
In the absence of LIF, ES cells will tend to differentiate but if LIF is present, this will force the cells to preferentially self-renew.
Does LIF work alone to act on the ESCs?
LIF alone cannot drive self-renewal, it must be in the presence of serum too. In serum-free conditions, LIF alone is insufficient to maintain pluripotency and block neural differentiation.
Ying et al 2003 showed that you need LIF and BMP4 (or BMP2) to sustain self-renewal and pluripotency. Without them you will see neural differentiation, turning on of Tuj1 and the turning off of Oct4.
How do LIF and BMP work together to sustain self-renewal?
BMPs induce Id genes via SMADs, these block entry into neural lineages. At the same time LIF via Stat3 inhibits BMPs from inducing mesoderm/endoderm. LIF and BMPs use competing actions to co-operate in combination to sustain self-renewal.
When they first isolated human embryonic stem cells what did they come across?
The first human embryonic stem cells were isolated in 1998. It was technically very difficult to do, the technologies used for mice weren’t easily used for humans. They found that there were some key differences between the nature of mouse and human ESCs as well. Mouse ESCs would grow in a domed column whereas human ESCs would grow in flat columns. Oct4, Sox2 and Nanog are present in both but some of the surface antigens are very different e.g. SSEA+ in mice, SSEA- in humans.
What are the conserved pathways in self-renewal in mice and humans?
Stat3 signalling (although works slightly differently) Nanog, Oct, Sox FGF and TGFb signalling BMPR1a microRNAs Methylation - X inactivation Cell cycle e.g. Rb tumour suppressor Igf2-H19
What are the differences in self-renewal in mice and humans?
LIFR-gp130 Requirement for activin/nodal signalling FGF signalling Cell cycle rates and cell death Rex1 (variable expression in hES) Surface antigens (SSEA and TRA)